Pediatric Sacral Neuromodulation for Voiding Dysfunction

Chapter

Abstract

Electrical stimulation of the lower urinary tract is a well established treatment for several etiologies of voiding dysfunction in adults, but its use in children is relatively novel. Voiding dysfunction accounts for roughly 30% of visits to a pediatric urologist (Rushton, Urol Clin North Am 22:75, 1995). The constellation of symptoms can be especially frustrating to the child, parents and physician given the frequent visits and numerous therapies. First line therapy is typically limited to behavioral modifications including timed voiding, adjustments to fluid intake, dietary modifications and treatment of bowel dysfunction. Additional treatment options include: biofeedback, anti-cholinergic and alpha-adrenergic medications, intravesical botulinum toxin injection and clean intermittent catheterization. In appropriately selected patients, sacral neuromodulation (SNM) can be used to treat children with medically refractory voiding dysfunction.

Keywords

Neuromodulation Bowel-bladder dysfunction Urodynamic study 

References

  1. 1.
    Rushton HG. Wetting and functional voiding disorders. Urol Clin North Am. 1995;22:75.PubMedGoogle Scholar
  2. 2.
    Humphreys MR, Vandersteen DR, Slezak JM, Hollatz P, Smith CA, Smith JE, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176(5):2227–31.CrossRefGoogle Scholar
  3. 3.
    Guys JM, Hadid M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673.CrossRefGoogle Scholar
  4. 4.
    Schober MS, Sulkowski JP, Lu PL, Minneci PC, Deans KJ, Teich S, et al. Sacral nerve stimulation for pediatric lower urinary tract dysfunction: development of a standardized pathway with objective urodynamic outcomes. J Urol. 2015;194(6):1721–7.CrossRefGoogle Scholar
  5. 5.
    Groenendijk P, Lycklama ANA, Ouwerkerk T, van den Hombergh U. Five-year follow-up after sacral neuromodulation: single center experience. Neuromodulation. 2007;10(4):363–8.CrossRefGoogle Scholar
  6. 6.
    Hoebeke P, Van Laecke E, Everaert K, Renson C, De Paepe H, Raes A, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166(6):2416–9.CrossRefGoogle Scholar
  7. 7.
    Dwyer ME, Vandersteen DR, Hollatz P, Reinberg Y. Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children. Urology. 2014;84:911–8.CrossRefGoogle Scholar
  8. 8.
    Haddad M, Besson R, Aubert D, Ravasse P, Lemelle J, El Ghoneimi A, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010;184(2):696–701.CrossRefGoogle Scholar
  9. 9.
    Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008;180(1):306–11.CrossRefGoogle Scholar
  10. 10.
    Stephany HA, Juliano TM, Clayton DB, Tanaka ST, Thomas JC, Adams MC, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190(4 Suppl):1516–22.CrossRefGoogle Scholar
  11. 11.
    McGee SM, Routh JC, Granberg CF, Roth TJ, Hollatz P, Vandersteen DR, et al. Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy. Urology. 2009;73:641–4.CrossRefGoogle Scholar
  12. 12.
    Clark C, Ngo T, Comiter CV, Anderson R, Kennedy W. Sacral nerve stimulator revision due to somatic growth. J Urol. 2011;186:1576–80.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Urology, William Beaumont HospitalRoyal OakUSA
  2. 2.Division of Pediatric Urology, William Beaumont HospitalRoyal OakUSA

Personalised recommendations